A great smile can be a powerful asset. It can create opportunities and set you up for success – much like the minimally invasive Laser Vision Correction procedure SMILE. Especially when you consider that 1 million eyes have already been treated with small incision lenticule extraction, better known as SMILE. With over 1,300 practicing SMILE surgeons worldwide and FDA approval in the US, SMILE offers great prospects for success.
SMILE is a laser eye surgery that already looks back on 10 years. First performed in 2007 by Walter Sekundo with a VisuMax® femtosecond laser from ZEISS, it became commercially available in 2011 with the launch of ReLEx® SMILE from ZEISS. Today, over 1,300 surgeons worldwide in over 65 countries have performed over 1 million SMILE procedures. As an FDA approved procedure, it offers practices an additional laser vision correction option to enhance their services portfolio.
As can be observed in various surgical specialties, there is a growing trend towards minimally invasive procedures and applications. With SMILE, that trend has also become the standard for laser vision correction. SMILE holds tremendous potential for significant practice growth. Thanks to ReLEx SMILE, refractive procedures grew an average of more than 200% per ZEISS VisuMax laser in China1. Also, SMILE and corneal inlays are expected to boost refractive volume by 8.3% in the U.S. in 20172.
SMILE is the first minimally invasive laser vision correction procedure. During SMILE eye surgery, a lenticule is created inside the intact cornea using the VisuMax femtosecond laser and is extracted through a small incision. The lenticule is removed, thereby achieving the desired vision correction.
As a minimally invasive approach, SMILE offers the potential for biomechanical stability of the cornea*, lower incidence of transient dry eye syndrome* and faster wound healing*.
More and more clinics are performing laser eye surgery with SMILE. Leading specialists provide insights on why they choose SMILE.
I operated on my own 18-year-old daughter with SMILE, so what more can I say?Dr. Petri Oksman - Medilaser Oy Tampere, Finland
Anyone not offering SMILE in the near future will simply not survive the highly competitive refractive markets.Dr. Sri Ganesh Nethradhama - Superspecialty Eye Hospital Bangalore, India
SMILE is the perfect solution for my demanding patients in the high price segment.Dr. Rainer Wiltfang - Smile Eyes Augenklinik am Airport Munich, Germany
Patients want quality of vision and a high level of safety. That’s why we choose SMILE. Small incision – great patient satisfaction.Dr. Joaquin Fernandez - Qvision Almeria, Spain
A rapidly growing number of refractive surgeons around the world are already treating patients with SMILE. Renowned specialists share experiences they have made and information they have gathered thus far with the minimally invasive procedure.
- Minimally invasive
- Does not require a flap
- Performed on one laser
- Gentle treatment experience
- Fast wound healing following surgery
We want to keep you informed about ZEISS products and events, as well as provide you useful and informative resources to benefit your practice and patients.
1 Source: market Scope Ophthalmic Market Perspectives, March 2017
2 Market Scope Ophthalmic Market Perspectives, March 2017
* Dry eye disease after refractive surgery: comparative outcomes of small incision lenticule extraction versus L ASIK. Ophthalmology 2015 Apr, Denoyer A, Landman E, Trinh L, Faure JF, Auclin F, Baudouin C.
The statements of the healthcare professionals giving this testimonials reflect only their personal opinions and experiences and do not necessarily reflect the opinions of any institution with whom they are affiliated.
The healthcare professionals giving this testimonial may have contractual relationship with Carl Zeiss Meditec, AG., and may have received financial compensation.